Patient Stories
-
ROBIN M.
In the three years since entering remission, I have become extremely active in cancer patient advocacy.
-
URSULA D.
It was time for me to make peace with who I really am—the good, the bad, and the ugly—and embrace it all. I needed to stop judging myself and start loving myself.
-
Daniel Shockley
To me, challenges are opportunities and being prepared along with retaining a positive outlook are key.
What’s New
Bristol-Myers Squibb’s Opdivo ® (nivolumab) + Low- Dose Yervoy ® (ipilimumab) is the First Immuno-Oncology Combination Approved for MSI-H/dMMR mCRC Patients Who Progressed Following Treatment with a Fluoropyrimidine, Oxaliplatin and Irinotecan